LumiraDx Limited Warrant
LMDXW
LMDXW was delisted on the 8th of January, 2024.
17 hedge funds and large institutions have $2.62M invested in LumiraDx Limited Warrant in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
13% more funds holding
Funds holding: 15 → 17 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $2.76M → $2.62M (-$141K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$1.1K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$85 |
| 3 |
CS
Clear Street
New York
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.08K |
| 2 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$550 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVS Health
Woonsocket,
Rhode Island
| $2.57M | – | – | – |
|
|
SM
2
Senvest Management
New York
| $31.3K | – | – | – |
|
|
3
Balyasny Asset Management
Chicago,
Illinois
| $6.78K | -$1.08K | -19,573 | -8% |
|
|
LP
4
LMR Partners
London,
United Kingdom
| $6K | – | – | – |
|
|
KL
5
KIM LLC
Wichita,
Kansas
| $3.74K | – | – | – |
|
|
MCM
6
Moore Capital Management
New York
| $1.34K | – | – | – |
|
|
MI
7
MMCAP International
Grand Cayman,
Cayman Islands
| $1.28K | – | – | – |
|
8
Walleye Capital
New York
| $897 | – | – | – |
|
|
CP
9
Covalent Partners
Concord,
Massachusetts
| $822 | – | – | – |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| $760 | +$85 | +1,550 | +6% |
|
11
Walleye Trading
New York
| $598 | – | – | – |
|
|
AA
12
Ancora Advisors
Cleveland,
Ohio
| $463 | -$550 | -10,000 | -39% |
|
|
CAM
13
Cresset Asset Management
Chicago,
Illinois
| $408 | – | – | – |
|
|
BTP
14
Bloom Tree Partners
New York
| $307 | – | – | – |
|
|
15
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $302 | +$1.1K | +20,000 | New |
|
16
Morgan Stanley
New York
| $56 | – | – | – |
|
|
CS
17
Clear Street
New York
| $3 | +$6 | +100 | New |
|
LMDXW Hedge Fund Activity: Q2 2023 in Review
17 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in LumiraDx Limited Warrant (LMDXW) for Q2 2023, worth a combined $2.62M — down 5.1% from $2.76M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new LMDXW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was CAPTRUST Financial Advisors, opening a new position worth an estimated $1.1K. The largest seller was Balyasny Asset Management, cutting an estimated $1.08K.
- 17 institutional investors held LumiraDx Limited Warrant (LMDXW) as of Q2 2023, up from 15 in Q1 2023.
- Funds reported $2.62M of LumiraDx Limited Warrant stock for Q2 2023, down 5.1% quarter-over-quarter.
- 2 funds opened new LumiraDx Limited Warrant positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest LumiraDx Limited Warrant buyer in Q2 2023 was CAPTRUST Financial Advisors, an estimated $1.1K added.
- The largest LumiraDx Limited Warrant seller in Q2 2023 was Balyasny Asset Management, an estimated $1.08K sold.
Based on aggregated 13F filings for Q2 2023.